ANAPTYSBIO, INC Annual Net Cash Provided by (Used in) Financing Activities in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Anaptysbio, Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2015 to 2023.
  • Anaptysbio, Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was -$13.6M, a 63.7% increase year-over-year.
  • Anaptysbio, Inc annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$59.3M, a 235% decline from 2022.
  • Anaptysbio, Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was $44M, a 82.6% decline from 2021.
  • Anaptysbio, Inc annual Net Cash Provided by (Used in) Financing Activities for 2021 was $252M.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$59.3M -$103M -235% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-11
2022 $44M -$208M -82.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-11
2021 $252M +$253M Jan 1, 2021 Dec 31, 2021 10-K 2024-03-11
2020 -$879K +$3.61M +80.4% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 -$4.49M -$228M -102% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-07
2018 $223M -$69.1M -23.6% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 $292M +$284M +3290% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-02
2016 $8.63M -$30.8M -78.1% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 $39.4M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.